Evidence map›Paper›PMID 41287097›Full record

ArticleClinical epigenetics2025

Investigating the pathogenesis of urolithiasis through gut microbiome, plasma metabolome and inflammatory proteome: a mediation Mendelian randomization study.

Guanwei Wu, Weiyu Zhu, Guoxiang Li, Yuexian Xu, Yingqing Liu, Lingsong Tao, Zongyao Hao

Abstract read
In one paragraph

Article in Clinical epigenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guanwei Wu *Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Weiyu Zhu *Department of Ultrasound, Affiliated Wuhu Hospital of East China Normal University, Wuhu, Anhui, China.
Guoxiang Li *Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Yuexian XuDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Yingqing LiuDepartment of Urology, Affiliated Wuhu Hospital of East China Normal University, Wuhu, Anhui, China.
Lingsong TaoDepartment of Urology, Affiliated Wuhu Hospital of East China Normal University, Wuhu, Anhui, China.
Zongyao HaoDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. haozongyao@ahmu.edu.cn.

Funding

Key Project of Wuhu Science and Technology Bureau 2023jc32the Key Scientific Research Project of Anhui Higher Education Institutions 2022AH051520
6 · The paper itself

Abstract

backgroundUrolithiasis is a multifactorial systemic metabolic disease influenced by genetic, environmental, and dietary factors. Although previous observational studies have established strong links between the gut microbiome, plasma metabolome, inflammatory proteome, and urolithiasis, may be influenced by various confounding factors. This study aims to elucidate the causal relationships between gut microbiota (GM) and urolithiasis, and to investigate whether plasma metabolites and inflammatory proteins mediate this interaction.

methodsWe utilized publicly available dataset from genome-wide association studies (GWAS) to obtain data on GM, plasma metabolites, inflammatory proteins and urolithiasis. To elucidate the causal relationship between GM and urolithiasis, we conducted bidirectional Mendelian randomization (MR) analyses. Additionally, a two-step MR approach was applied to investigate whether GM contributes to the development of urolithiasis via plasma metabolites and inflammatory proteins, quantifying the mediation effect. Inverse variance weighting (IVW) was the primary method, with Bayesian weighted Mendelian randomization (BWMR), MR-Egger, and weighted median (WM) analyses used to ensure the robustness of our findings. Tests for horizontal pleiotropy and heterogeneity were conducted to confirm the reliability of the results. OUTCOME: MR analyses identified causal relationships between seven GM taxa and six metabolic pathways with urolithiasis, while urolithiasis induced changes in 13 GM taxa and five metabolic pathways. Additionally, 43 plasma metabolites (27 identified, 8 unidentified, and 8 metabolite ratios) and six inflammatory proteins were identified as potential mediators in the GM-urolithiasis connection. Through two-step mediation analysis, 13 causal pathways were identified. After excluding metabolic pathways and unidentified metabolites, we determined that galactonate and LAP-TGF-β1 mediate the relationship between Bacteroides faecis, Alistipes finegoldii, and urolithiasis, with mediation proportions of 16.99% (P = 0.0371) and 9.61% (P = 0.0469), respectively.

conclusionThe present MR analysis provides evidence supporting causal relationships between specific GM taxa and urolithiasis, with plasma metabolites and inflammatory proteins emerging as potential mediators.

Indexed as

Gastrointestinal MicrobiomeMendelian Randomization AnalysisMetabolomeProteomeUrolithiasisGenome-Wide Association StudyHumansInflammationProteomeGut-kidney axisGut microbiotaInflammatory proteinsMendelian randomizationPlasma metabolitesUrolithiasis

Identifiers

PMID41287097
PMCPMC12764163

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.